Diagnostic services provider Dr Lal Path Labs on Thursday said its consolidated net profit declined 57 per cent to ₹58 crore for the first quarter ended June 30, 2022.
The company had reported a net profit of ₹134 crore in the April-June period of the last fiscal.
Revenue from operations declined to ₹503 crore in the period from ₹607 crore a year ago, Dr Lal PathLabs said in a regulatory filing.
The company's board has also declared an interim dividend of ₹6 per share for the current fiscal.
Shares of the company were trading 1.27 per cent down at ₹2,142.7 apiece on BSE.